StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
8
Publishing Date
2023 - 11 - 07
1
2023 - 10 - 27
1
2023 - 03 - 27
1
2022 - 06 - 20
1
2022 - 06 - 03
1
2021 - 10 - 11
1
2021 - 09 - 28
1
2021 - 09 - 24
1
Sector
Health technology
8
Tags
Active
1
Agreement
1
Application
2
Approval
3
Breast
1
Breast cancer
1
Cancer
2
China
2
Collaboration
1
Conference
1
Disease
2
Drug
2
Expected
1
Genomics
1
Group
1
Growing
1
Growth
1
Hiv
1
Hypertension
1
Infections
1
Kisqali
1
Lipodystrophy
1
Market
1
N/a
7
Nefecon
1
Nephropathy
1
New drug
1
News
1
Nivolumab
1
Novartis
1
Phase 2
1
Phase 2 results
1
Positive
1
Profitable
1
Report
1
Research
1
Response
1
Results
1
Service
1
Services
1
System
1
Therapy
1
Treatment
3
Trial
2
Update
1
Vaccine
2
Valneva
2
Virus
1
Vla15
1
Entities
Astrazeneca plc
1
Bristol-myers squibb company
1
Eli lilly and company
1
Glaxosmithkline plc
1
Neurocrine biosciences, inc.
1
Novartis ag
1
Pfizer, inc.
8
Sanofi
1
Symbols
AAPL
25
ABB
32
ABBV
20
ABLZF
25
ABT
20
ACN
26
ADBE
15
ADXN
36
ALSMY
22
AOMFF
22
ARGX
29
ARVL
97
AVGO
15
BLK
16
BNPQF
270
BNPQY
270
CMCL
23
CMI
15
CYAD
17
DOW
15
EQNR
73
ERIC
43
FLNG
35
FNCTF
96
GMHLF
16
GMHLY
16
GOOG
37
GOOGL
37
HON
42
IDBA
18
IPHA
27
JCI
21
JNJ
81
KBCSF
18
KBCSY
18
LAES
30
MDT
20
MS
40
MT
15
NVO
33
NVS
69
NVSEF
58
OBSV
25
OCX
16
OOMA
27
PHG
15
PPRUF
15
PPRUY
15
REGN
27
SAP
44
SAPGF
35
SNY
156
SNYNF
103
STLA
16
STOHF
53
TEVJF
16
TMO
24
VEON
29
VRNA
18
WKEY
67
Exchanges
Nasdaq
2
Nyse
8
Crawled Date
2023 - 11 - 07
1
2023 - 10 - 27
1
2023 - 03 - 27
1
2022 - 06 - 20
1
2022 - 06 - 03
1
2021 - 10 - 11
1
2021 - 09 - 28
1
2021 - 09 - 24
1
Crawled Time
00:00
25
00:01
1
00:20
4
01:00
15
02:00
6
03:00
1
04:00
4
04:20
1
05:00
9
05:03
1
05:10
1
06:00
8
06:03
2
07:00
10
08:00
3
08:20
3
09:00
11
09:01
1
10:00
16
10:51
1
11:00
66
11:01
1
12:00
90
12:03
1
12:15
4
12:20
16
12:30
12
12:34
1
13:00
45
13:01
1
13:07
1
13:14
1
13:15
3
13:17
1
13:20
6
13:27
1
13:30
6
13:50
1
13:55
1
14:00
39
14:03
1
14:15
2
14:20
5
14:30
1
15:00
34
15:15
3
15:20
9
15:21
1
15:28
1
15:30
4
16:00
39
16:20
2
17:00
27
18:00
23
18:31
2
19:00
20
20:00
17
21:00
27
22:00
26
23:00
14
Source
www.biospace.com
1
www.globenewswire.com
4
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Pfe
crawled time :
06:00
save search
Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference
Published:
2023-11-07
(Crawled : 06:00)
- globenewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-15.59%
|
O:
-0.32%
H:
0.98%
C:
0.55%
conference
valneva
Everest Medicines Announces New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy
Published:
2023-10-27
(Crawled : 06:00)
- prnewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-15.53%
|
O:
-0.32%
H:
0.23%
C:
-3.06%
nefecon
nephropathy
drug
approval
treatment
application
Novartis Kisqali® Phase III NATALEE trial meets primary endpoint at interim analysis demonstrating clinically meaningful benefit in broad population of patients with early breast cancer
Published:
2023-03-27
(Crawled : 06:00)
- globenewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-34.84%
|
O:
0.37%
H:
0.2%
C:
-0.79%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
18.27%
|
O:
6.51%
H:
1.75%
C:
1.4%
kisqali
breast
cancer
novartis
trial
Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15
Published:
2022-06-20
(Crawled : 06:00)
- globenewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
Email alert
Add to watchlist
vla15
valneva
disease
collaboration
vaccine
agreement
update
Global Panic Disorders Market Insights | Size | Shares | Trends | Growth | Industry Analysis [2020-2030] Panic disorders, also known as anxiety disorder deals with recurrent and unexpected panic attacks. PET-CT Scanner Devices Market: Competitive Landscape Analysis With Forecast by 2031 Wilmington, Delaware: According to the report, the global PET-CT scanner devices market was valued over US$ 200 Mn in 2020 and is projected to expand at a CAGR of ~3% from 2021 to 2031. Portal Hypertension Market Insights | Current Trends | Growth Opportunity | Global Industry Analysis [2020-2030] At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. Spatial Genomics & Transcriptomics Market to Experience Significant Growth by 2027 Wilmington, Delaware: The spatial genomics & transcriptomics market is prognosticated to bring profitable growth during the assessment period of 2019-2027. Teleradiology Services Market to Make Great Impact in Near Future by 2031 Wilmington, Delaware: According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020. Anti-depressants Drugs and Therapies Market to Witness a Pronounce Growth by 2025 Wilmington, Delaware: Anti-depressants medications lower the symptoms of depression, dysthymia, chronic depression, and anxiety disorders. B-Cell Non-Hodgkin’s Lymphoma (NHL) Market to Offer Ample Growth Opportunities by 2027 Wilmington, Delaware: Non-Hodgkin’s lymphoma is a group of heterogeneous proliferative malignancies. Heightening Healthcare Spending Opening Growth Avenues for Collateral Ligament Stabilizer System Market, Reaching US$ 3.5 Billion in 2032: Fact.MR Study Fact.MR – A Market Research and Competitive Intelligence Provider: The global collateral ligament stabilizer system market is expected to reach US$ 3.5 Billion by the end of the 2022-2032 forecast period, growing at a CAGR of 6.1%, concludes a recently published report by Fact.MR. Breast Cancer Liquid Biopsy Market Trends, Growth, Analysis and Future Scope, 2026 Wilmington, Delaware: A biopsy is a tissue or cell sample taken from any part of the patient’s body and examined in the lab for the detection of cancer. Cerebral Palsy Market Size, Shares, Trends and Growth | Global Industry Analysis [2020-2030] The global cerebral palsy market is picking up steam due to increasing awareness about the condition amongst parents. Continuous Glucose Monitoring Market: Competitive Research and Precise Outlook 2021 to 2028 Wilmington, Delaware: The global continuous glucose monitoring market depicts the presence of a large competitive vendor landscape, says Transparency Market Research on the basis of a newly research report. Crow’s Feet Market Key Trends and Opportunity Analysis up to 2026 Albany NY, United States: The demand within the global crow’s feet market has been escalating on account of vital advancements in the field of dermatology in recent times. HIV Associated Lipodystrophy Syndrome Market Insights | Global Industry Analysis [2020-2030] HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus -infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Global Mail Service Pharmacy Market | Size | Shares | Trends | Growth | Forecast [2020-2030]
Published:
2022-06-03
(Crawled : 06:00)
- biospace.com/
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-26.78%
|
O:
-1.55%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-11.71%
|
O:
-0.94%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
9.0%
|
O:
-0.4%
H:
4.05%
C:
-1.35%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-49.67%
|
O:
0.57%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-4.6%
|
O:
-0.14%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
138.4%
|
O:
-2.25%
H:
0.0%
C:
0.0%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-35.09%
|
O:
-1.4%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-12.28%
|
O:
-0.09%
H:
0.0%
C:
0.0%
NBIX
|
News
M
|
$138.91
-0.84%
-0.85%
880K
|
Health Technology
|
52.15%
|
O:
2.29%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
6.56%
|
O:
-0.56%
H:
0.82%
C:
-0.64%
lipodystrophy
treatment
research
system
active
services
report
service
growing
hiv
profitable
hypertension
genomics
expected
virus
approval
cancer
growth
group
market
breast cancer
infections
Kintor Pharma Announces China NMPA Approves Clinical Trial of ALK-1 and Nivolumab Combination Therapy for the First-line Treatment of Advanced Hepatocellular Carcinoma
Published:
2021-10-11
(Crawled : 06:00)
- prnewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-38.23%
|
O:
-0.38%
H:
0.4%
C:
-0.92%
treatment
china
therapy
trial
nivolumab
Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate
Published:
2021-09-28
(Crawled : 06:00)
- globenewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-39.59%
|
O:
-1.15%
H:
0.49%
C:
-0.07%
disease
phase 2
positive
phase 2 results
results
vaccine
response
Everest Medicines Announces Approval of Investigational New Drug Application by China NMPA for SPR206
Published:
2021-09-24
(Crawled : 06:00)
- prnewswire.com
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-40.44%
|
O:
-0.27%
H:
0.0%
C:
0.0%
new drug
china
drug
approval
application
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.